The European Union’s medicines authority says it has begun evaluating a new drug for treating COVID-19 patients who do not require extra oxygen but are at increased risk of developing severe symptoms of the disease
Related posts
-
Mundelein Mayor Steve Lentz honored as he prepares to leave office
After 12 years as mayor and four before that as a trustee, Steve Lentz’s time as... -
Resident suffers serious burns after cooking mishap in Algonquin garage
An Algonquin man suffered serious burns in a cooking-related mishap inside a garage on the 0-100... -
Rolling Meadows police sergeant on leave after arrest in road rage shooting
A Rolling Meadows police sergeant is on unpaid leave after being charged in connection with a...